Characterizing trachoma elimination using serology.

Kamau, EORCID logo; Ante-Testard, PAORCID logo; Gwyn, SORCID logo; Blumberg, SORCID logo; Abdalla, Z; Aiemjoy, KORCID logo; Amza, A; Aragie, S; Arzika, AM; Awoussi, MS; +58 more...Bailey, RLORCID logo; Butcher, R; Callahan, EK; Chaima, D; Dawed, AA; Díaz, MISORCID logo; Domingo, AS; Drakeley, CORCID logo; Elshafie, BE; Emerson, PM; Fornace, K; Gass, K; Goodhew, EB; Hammou, J; Harding-Esch, EMORCID logo; Hooper, P; Kadri, B; Kalua, K; Kanyi, S; Kasubi, M; Kello, ABORCID logo; Ko, R; Lammie, PJ; Lescano, AGORCID logo; Maliki, R; Masika, MP; Migchelsen, SJORCID logo; Nassirou, B; Nesemann, JMORCID logo; Parameswaran, N; Pomat, WORCID logo; Renneker, KKORCID logo; Roberts, CORCID logo; Rymil, P; Sata, E; Senyonjo, L; Seife, F; Sillah, A; Sokana, O; Srivathsan, AORCID logo; Tadesse, Z; Taleo, F; Taylor, EM; Tekeraoi, R; Togbey, K; West, SK; Wickens, KORCID logo; William, T; Wittberg, DM; Yeboah-Manu, DORCID logo; Youbi, M; Zeru, T; Keenan, JDORCID logo; Lietman, TMORCID logo; Solomon, AWORCID logo; Nash, SD; Martin, DL; Arnold, BFORCID logo and (2025) Characterizing trachoma elimination using serology. Nature communications, 16 (1). 5545-. ISSN 2041-1723 DOI: 10.1038/s41467-025-60581-z
Copy

Trachoma is targeted for global elimination as a public health problem by 2030. Measurement of IgG antibodies in children is being considered for surveillance and programmatic decision-making. There are currently no programmatic guidelines based on serology, which represents a generalizable problem in seroepidemiology and disease elimination. Here, we collate Chlamydia trachomatis Pgp3 and CT694 IgG measurements from 48 serosurveys across Africa, Latin America, and the Pacific Islands (41,168 children ages 1-5 years) and propose a novel approach to estimate the probability that population C. trachomatis transmission is below or above levels requiring ongoing programmatic action. We determine that trachoma programs could halt control measures with >90% certainty when seroconversion rates (SCRs) are ≤2.2 per 100 person-years. Conversely, SCRs ≥4.5 per 100 person-years correspond with >90% certainty that further control interventions are needed. More extreme SCR thresholds correspond with higher levels of confidence of elimination (lower SCR) or ongoing action needed (higher SCR). This study demonstrates a robust approach for using trachoma serosurveys to guide elimination program decisions.

mail Request Copy

picture_as_pdf
Kamau-etal-2025-Characterizing-trachoma-elimination.pdf
subject
Published Version
lock
Restricted to Repository staff only
Available under Creative Commons: Attribution 4.0

Request Copy

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads